Agios Pharmaceuticals Inc (AGIO.O) Analysts | Reuters.com
Edition:
United States

Agios Pharmaceuticals Inc (AGIO.O)

AGIO.O on Nasdaq

44.27USD
24 Jun 2016
Change (% chg)

$-4.23 (-8.72%)
Prev Close
$48.50
Open
$45.76
Day's High
$47.28
Day's Low
$44.21
Volume
957,456
Avg. Vol
809,024
52-wk High
$120.96
52-wk Low
$33.50

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.48 December 25 Jun 2016

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 0 0 0
(2) OUTPERFORM 4 3 3 2
(3) HOLD 3 5 5 5
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.25 2.62 2.62 2.71

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-16 8 39.62 204.92 1.00 --
Quarter Ending Sep-16 8 14.20 59.49 0.00 --
Year Ending Dec-16 9 113.03 246.03 49.28 51.27
Year Ending Dec-17 8 68.03 214.71 3.00 105.69
Earnings (per share)
Quarter Ending Jun-16 8 -0.48 3.80 -1.48 --
Quarter Ending Sep-16 8 -1.34 0.03 -1.96 --
Year Ending Dec-16 9 -3.16 0.30 -5.04 -3.72
Year Ending Dec-17 9 -4.54 0.79 -8.93 -3.24

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-16 20.94 31.28 10.35 49.42
Quarter Ending Dec-15 29.22 6.22 23.00 78.72
Quarter Ending Sep-15 16.07 5.48 10.59 65.90
Quarter Ending Jun-15 25.75 13.22 12.53 48.67
Quarter Ending Mar-15 10.86 34.20 23.34 214.86
Earnings (per share)
Quarter Ending Mar-16 -0.79 -0.61 0.18 -23.09
Quarter Ending Dec-15 -0.47 -1.08 0.61 -129.59
Quarter Ending Sep-15 -0.80 -1.07 0.28 -34.59
Quarter Ending Jun-15 -0.46 -0.85 0.39 -84.78
Quarter Ending Mar-15 -0.92 -0.13 0.79 -85.91

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Jun-16 39.62 39.62 39.63 8.19 --
Quarter Ending Sep-16 14.20 14.20 13.79 14.66 --
Year Ending Dec-16 113.03 113.03 115.81 79.01 51.27
Year Ending Dec-17 68.03 68.03 68.02 53.50 105.69
Earnings (per share)
Quarter Ending Jun-16 -0.48 -0.48 -0.48 -1.22 --
Quarter Ending Sep-16 -1.34 -1.34 -1.22 -1.07 --
Year Ending Dec-16 -3.16 -3.16 -3.02 -3.61 -3.72
Year Ending Dec-17 -4.54 -4.56 -4.39 -3.91 -3.24

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-16 0 0 0 1
Quarter Ending Sep-16 0 0 2 0
Year Ending Dec-16 0 0 0 2
Year Ending Dec-17 0 0 1 0
Earnings
Quarter Ending Jun-16 0 0 0 1
Quarter Ending Sep-16 0 0 0 1
Year Ending Dec-16 0 0 0 1
Year Ending Dec-17 1 0 1 2

Analyst Research Reports

Report Title Price
Provider : ValuEngine, Inc.
$25.00
Provider : Pechala's Reports
$25.00
Provider : Reuters Investment Profile
$20.00
Provider : Thomson Reuters Stock Report
$25.00
Provider : Ford Investor Services, Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.